AtonRa Partners’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $243K | Sell |
2,446
-271
| -10% | -$27K | 0.48% | 96 |
|
|
2023
Q3 | $281K | Sell |
2,717
-570
| -17% | -$58.9K | 0.59% | 83 |
|
|
2023
Q2 | $399K | Sell |
3,287
-118
| -3% | -$14.3K | 0.62% | 76 |
|
|
2023
Q1 | $523K | Sell |
3,405
-341
| -9% | -$52.4K | 0.76% | 55 |
|
|
2022
Q4 | $673K | Sell |
3,746
-1,013
| -21% | -$182K | 0.86% | 52 |
|
|
2022
Q3 | $563K | Sell |
4,759
-142
| -3% | -$16.8K | 0.55% | 81 |
|
|
2022
Q2 | $700K | Sell |
4,901
-4,355
| -47% | -$622K | 0.64% | 69 |
|
|
2022
Q1 | $1.59M | Sell |
9,256
-4,482
| -33% | -$772K | 0.87% | 44 |
|
|
2021
Q4 | $3.49M | Buy |
13,738
+69
| +0.5% | +$17.5K | 1.21% | 28 |
|
|
2021
Q3 | $5.26M | Sell |
13,669
-1,905
| -12% | -$733K | 1.76% | 10 |
|
|
2021
Q2 | $3.66M | Sell |
15,574
-9,180
| -37% | -$2.16M | 1.34% | 22 |
|
|
2021
Q1 | $3.24M | Buy |
24,754
+2,194
| +10% | +$287K | 1.45% | 14 |
|
|
2020
Q4 | $2.36M | Buy |
+22,560
| New | +$2.36M | 1.16% | 37 |
|